[
  {
    "ts": null,
    "headline": "Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 49% Undervaluation?",
    "summary": "Key Insights Amgen's estimated fair value is US$583 based on 2 Stage Free Cash Flow to Equity Current share price of...",
    "url": "https://finnhub.io/api/news?id=66abccd18b90b920150f1e4cd9fc92d0066f0b44f40ed1bf21ac60d18bdc5a20",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732456810,
      "headline": "Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 49% Undervaluation?",
      "id": 131614618,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Key Insights Amgen's estimated fair value is US$583 based on 2 Stage Free Cash Flow to Equity Current share price of...",
      "url": "https://finnhub.io/api/news?id=66abccd18b90b920150f1e4cd9fc92d0066f0b44f40ed1bf21ac60d18bdc5a20"
    }
  }
]